Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fasting Conditions

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
An open label, balanced, randomized, two‐treatment, four‐period, two‐sequence, single dose, crossover, fully replicated oral bioequivalence study of Tetrabenazine Tablets 25 mg of Dr. Reddy's Laboratories Limited, India comparing with XENAZINE® (tetrabenazine) Tablets 25 mg of Lundbeck Inc., USA in healthy, adult, human subjects under fasting conditions.
Epistemonikos ID: 8d1375843bbb22fd3d926ef785735b5da0f89a5a
First added on: May 21, 2024